Diagnosing prostate cancer early can potentially identify tumours when they are at an early stage and intervention might improve treatment options and survival; however, studies have suggested that PSA alone has poor senstivity to determine the presence of prostate cancer for any risk stratification category.2 The gene discussed is KLK3; the disease is Familial prostate cancer.